COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

被引：0
|
作者：
Autore, Francesco [1 ]
Visentin, Andrea [2 ]
Deodato, Marina [3 ]
Vitale, Candida [4 ]
Galli, Eugenio [1 ]
Fresa, Alberto [1 ]
Fazzi, Rita [5 ]
Sanna, Alessandro [6 ]
Olivieri, Jacopo [7 ]
Scortechini, Ilaria [8 ]
Principe, Maria Ilaria Del [9 ]
Sportoletti, Paolo [1 ,10 ,11 ]
Innocenti, Idanna [1 ]
Coscia, Marta [4 ]
Tedeschi, Alessandra [3 ]
Trentin, Livio [2 ]
Candoni, Anna [12 ]
Busca, Alessandro [4 ]
Pagano, Livio [1 ,2 ,13 ]
Laurenti, Luca [1 ,13 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Lab & Infettivolog, Rome, Italy
[2] Univ Padua, Dept Med, Hematol Unit, Padua, Italy
[3] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy
[4] AOU Citta Salute Sci Torino, Div Hematol, Turin, Italy
[5] Azienda Osped Univ Pisana, UO Ematol, Pisa, Italy
[6] Azienda Osped Univ Careggi, Dept Oncol, Hematol Unit, Florence, Italy
[7] Azienda Sanit Univ Friuli Cent, Clin Ematol Udine, Udine, Italy
[8] Azienda osped Univ Marche, Clin Ematol, Ancona, Italy
[9] Univ Roma Tor Vergata, Dipartimento Biomed Prevenz, Rome, Italy
[10] Univ Perugia, Inst Hematol, Dept Med & Surg, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[11] Univ Perugia, Ctr Hemato Oncol Res CREO, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[12] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Sect Haematol, Modena, Italy
[13] Univ Cattolica Sacro Cuore, Dipartimento Diagnost Immagini Radioterapia Oncolo, Dipartimento Diagnostica Immagini, Rome, Italy
来源：
BLOOD ADVANCES | 2025年 / 9卷 / 01期
关键词：
D O I：
10.1182/bloodadvances.2024013792
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 165
页数：4
相关论文
共 50 条
  • [41] Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19
    Wilber, Eli
    Piantadosi, Anne
    Babiker, Ahmed
    McLendon, Kaleb
    O'Sick, William
    Fitts, Eric
    Webster, Andrew S.
    Verkerke, Hans
    Kim, James S.
    Phadke, Varun K.
    Rouphael, Nadine
    Titanji, Boghuma K.
    Blake, William T.
    Howard-Anderson, Jessica
    Roback, John D.
    Lam, Wilbur A.
    Damhorst, Gregory L.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
  • [42] COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
    Meca-Lallana, Virginia
    Aguirre, Clara
    Rio, Beatrizdel
    Cardenoso, Laura
    Alarcon, Teresa
    Vivancos, Jose
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [43] Longitudinal COVID-19 immune trajectories in autoimmune patients on anti-CD20 therapy
    Bazzi, S.
    Maguire, C.
    Holay, N.
    Geltman, J.
    Hurley, K.
    Ehrlich, L.
    Triplett, T.
    Melamed, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 230 - 230
  • [44] Progression of COVID-19 in a Patient on Anti-CD20 Antibody Treatment: Case Report and Literature Review
    Burgener, Sebastian
    Rochat, Philippe
    Dollenmaier, Guenter
    Benz, Gabriel
    Kistler, Andreas D.
    Fulchini, Rosamaria
    CASE REPORTS IN INFECTIOUS DISEASES, 2022, 2022
  • [45] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Yoshioka, Satoshi
    Maruoka, Hayato
    Nasu, Seiko
    Nishioka, Tomomi
    Sakizono, Kenji
    Mitsuyuki, Satoshi
    Kubo, Tomoyo
    Okada, Naoki
    Nakagawa, Daishi
    Kamijo, Kimimori
    Imoto, Hiroharu
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [46] Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
    Masashi Nishikubo
    Yoshimitsu Shimomura
    Ryusuke Yamamoto
    Satoshi Yoshioka
    Hayato Maruoka
    Seiko Nasu
    Tomomi Nishioka
    Kenji Sakizono
    Satoshi Mitsuyuki
    Tomoyo Kubo
    Naoki Okada
    Daishi Nakagawa
    Kimimori Kamijo
    Hiroharu Imoto
    Yuya Nagai
    Nobuhiro Hiramoto
    Noboru Yonetani
    Tadakazu Kondo
    Chisato Miyakoshi
    Asako Doi
    Takayuki Ishikawa
    Blood Cancer Journal, 13
  • [47] Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Yamamoto, Ryusuke
    Maruoka, Hayato
    Nasu, Seiko
    Sakizono, Kenji
    Nagai, Yuya
    Hiramoto, Nobuhiro
    Yonetani, Noboru
    Kondo, Tadakazu
    Miyakoshi, Chisato
    Doi, Asako
    Ishikawa, Takayuki
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (03) : 821 - 825
  • [48] A Phase I study of LFB-R603, a Novel Anti-CD20 Antibody, in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)
    Cartron, Guillaume
    Cazin, Bruno
    Coiffier, Bertrand
    Lepretre, Stephane
    Feugier, Pierre
    Aurran, Therese
    Chartier, Guylene
    Sadoun, Alain
    Ribrag, Vincent
    BLOOD, 2010, 116 (21) : 1015 - 1016
  • [49] Apoptotic induction by anti-CD20 antibodies in chronic lymphocytic leukemia: comparison of rituximab and obinutuzumab
    Reslan, Lina
    Dalle, Stephane
    Herveau, Stephanie
    Perrial, Emeline
    Dumontet, Charles
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 188 - 190
  • [50] Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab
    Pickartz, T
    Ringel, F
    Wedde, M
    Renz, H
    Klein, A
    von Neuhoff, N
    Dreger, P
    Kreuzer, KA
    Schmidt, CA
    Srock, S
    Schoeler, D
    Schriever, F
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) : 1410 - 1416
12345